Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of- opportunity study

Journal for ImmunoTherapy of Cancer

Oliva M, Chepeha D, Araujo D, et al. Antitumor Immune Effects of Pre-operative Sitravatinib and Nivolumab Lead to Major Clinical and Pathological Responses in Oral Cavity Cancer: The SNOW Window of Opportunity Study. Journal for ImmunoTherapy of Cancer, 9(10), e003476.